TipRanks
Advertisement
Advertisement
AbbVie Closes Apogee Acquisition to Expand Immunology Portfolio
PremiumCompany AnnouncementsAbbVie Closes Apogee Acquisition to Expand Immunology Portfolio
13d ago
AbbVie completes acquisition of Apogee for $135.11 per share in cash
Premium
The Fly
AbbVie completes acquisition of Apogee for $135.11 per share in cash
13d ago
AbbVie’s Allergan expands SkinMedica’s portfolio with Barrier Calming Cream
Premium
The Fly
AbbVie’s Allergan expands SkinMedica’s portfolio with Barrier Calming Cream
15d ago
AbbVie Raises $9 Billion Debt to Fund Acquisition
PremiumCompany AnnouncementsAbbVie Raises $9 Billion Debt to Fund Acquisition
29d ago
AbbVie price target raised to $300 from $295 at Wells Fargo
Premium
The Fly
AbbVie price target raised to $300 from $295 at Wells Fargo
1M ago
AbbVie upgraded to Outperform from Peer Perform at Wolfe Research
Premium
The Fly
AbbVie upgraded to Outperform from Peer Perform at Wolfe Research
1M ago
AbbVie’s Botox Cosmetic sBLA for masseter muscle prominence accepted by FDA
PremiumThe FlyAbbVie’s Botox Cosmetic sBLA for masseter muscle prominence accepted by FDA
1M ago
AbbVie’s Allergan Aesthetics receives FDA approval of sBLA for Botox Cosmetic
Premium
The Fly
AbbVie’s Allergan Aesthetics receives FDA approval of sBLA for Botox Cosmetic
1M ago
AbbVie price target raised to $288 from $261 at Guggenheim
Premium
The Fly
AbbVie price target raised to $288 from $261 at Guggenheim
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100